相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats
Per Aspenberg et al.
ACTA ORTHOPAEDICA (2008)
Angiotensin II accelerates osteoporosis by activating osteoclasts
Hideo Shimizu et al.
FASEB JOURNAL (2008)
Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss
Fumitaka Mizoguchi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment
Benedetto Sacchetti et al.
CELL (2007)
Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption
Noriaki Ono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Low-intensity pulsed ultrasound (LIPUS) induces RANKL, MCP-1, and MIP-1β expression in osteoblasts through the angiotensin II type 1 receptor
Kenjiro Bandow et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Osteopontin is required for mechanical stress-dependent signals to bone marrow cells
Muneaki Ishijima et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Local production of angiotensin II in the subfornical organ causes elevated drinking
Koji Sakai et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
Silvia Migliaccio et al.
CLINICAL INTERVENTIONS IN AGING (2007)
Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization
Norihiro Nagai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Chen Zhao et al.
CELL METABOLISM (2006)
The use of parathyroid hormone in the treatment of osteoporosis
Monica Girotra et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2006)
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study
L Rejnmark et al.
JOURNAL OF HYPERTENSION (2006)
Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow
Y Katayama et al.
CELL (2006)
Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system
H Kondo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease
M Loghman-Adham et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Leptin regulation of bone resorption by the sympathetic nervous system and CART
F Elefteriou et al.
NATURE (2005)
The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation
M Morinobu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis
M Usui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins
K Miyazono et al.
ONCOGENE (2004)
Forearm endothelial function and bone mineral loss in postmenopausal women
M Sanada et al.
ATHEROSCLEROSIS (2004)
A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy
T Senbonmatsu et al.
EMBO JOURNAL (2003)
Minireview: Overview of the renin-angiotensin system - An endocrine and paracrine system
JL Lavoie et al.
ENDOCRINOLOGY (2003)
Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation
K Kitahara et al.
ENDOCRINOLOGY (2003)
Leptin regulates bone formation via the sympathetic nervous system
S Takeda et al.
CELL (2002)
Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin
H Ihara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)